Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for reducing blood loss during laparoscopic surgery for severe endometriosis
ACTRN12618001318279Phase 4Recruiting
- Sponsor
- The Royal Women's Hospital
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in endometriosis comparing Tranexamic acid with Placebo (2 arms). Primary endpoint: Weighed blood loss. Started Aug 2018; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
endometriosis
Beyond the preview
Go deeper on ACTRN12618001318279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001318279.